Europe — EMA

Pacligen (Paclitaxel)

Paclitaxel, the active ingredient in Pacligen, is an antineoplastic presented as a strength/form for intravenous use. It treats various malignant neoplasms in adult patients.

Paclitaxel

Request sourcing

Pack/s

What is Paclitaxel?

Paclitaxel, the active ingredient in Pacligen, is an antineoplastic presented as a strength/form for intravenous use. It treats various malignant neoplasms in adult patients. GNH USA supplies Pacligen as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres worldwide.

What is Paclitaxel used for?

Pacligen is employed in oncology for cancers that respond to microtubule‑targeting therapy. - Breast cancer: improves the overall response rate when combined with anthr‑ and tax‑ based regimens. - Ovarian cancer: used as part of first line treatment with carboplatin and paclitaxel regimens ind - Lung .... ... . - ... .... . - .... .... . - ...

What are the side effects of Paclitaxel?

...

What precautions apply to Paclitaxel?

...

What does Paclitaxel interact with?

metatitle

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →